These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12174889

  • 1. Benzo[b]-1,8-naphthyridine derivatives: synthesis and reversal activity on multidrug resistance.
    Misbahi H, Brouant P, Hevér A, Molnár AM, Wolfard K, Spengler G, Mefetah H, Molnár J, Barbe J.
    Anticancer Res; 2002; 22(4):2097-101. PubMed ID: 12174889
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines.
    Deady LW, Rodemann T, Zhuang L, Baguley BC, Denny WA.
    J Med Chem; 2003 Mar 13; 46(6):1049-54. PubMed ID: 12620081
    [Abstract] [Full Text] [Related]

  • 3. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
    Molnar J, Molnar A, Mucsi I, Pinter O, Nagy B, Varga A, Motohashi N.
    In Vivo; 2003 Mar 13; 17(2):145-9. PubMed ID: 12792975
    [Abstract] [Full Text] [Related]

  • 4. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Mar 13; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 5. Novel multidrug resistance reversal agents.
    Berger D, Citarella R, Dutia M, Greenberger L, Hallett W, Paul R, Powell D.
    J Med Chem; 1999 Jun 17; 42(12):2145-61. PubMed ID: 10377220
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.
    Mastalarz H, Jasztold-Howorko R, Rulko F, Croisy A, Carrez D.
    Arch Pharm (Weinheim); 2004 Aug 17; 337(8):434-9. PubMed ID: 15293262
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
    Wesolowska O, Molnár J, Motohashi N, Michalak K.
    Anticancer Res; 2002 Aug 17; 22(5):2863-7. PubMed ID: 12530010
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
    Tsuzuki Y, Tomita K, Shibamori K, Sato Y, Kashimoto S, Chiba K.
    J Med Chem; 2004 Apr 08; 47(8):2097-109. PubMed ID: 15056007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
    Tsuzuki Y, Tomita K, Sato Y, Kashimoto S, Chiba K.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3189-93. PubMed ID: 15149673
    [Abstract] [Full Text] [Related]

  • 16. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
    Molnár J, Szabo D, Mándi Y, Mucsi I, Fischer J, Varga A, König S, Motohashi N.
    Anticancer Res; 1998 Jun 21; 18(4C):3033-8. PubMed ID: 9713505
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and multidrug-resistance modulating activity of a series of thienothiazines.
    Chiba P, Erker T, Galanski M, Hitzler M, Ecker GF.
    Arch Pharm (Weinheim); 2002 May 21; 335(5):223-8. PubMed ID: 12210779
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
    Engi H, Sakagami H, Kawase M, Parecha A, Manvar D, Kothari H, Adlakha P, Shah A, Motohashi N, Ocsovszki I, Molnár J.
    In Vivo; 2006 May 21; 20(5):637-43. PubMed ID: 17091771
    [Abstract] [Full Text] [Related]

  • 20. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
    Danko B, Martins A, Chuang DW, Wang HC, Amaral L, Molnár J, Chang FR, Wu YC, Hunyadi A.
    Anticancer Res; 2012 Jul 21; 32(7):2863-9. PubMed ID: 22753749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.